Register Now - 2027 EU/UK Biotech & Life Sciences Board Remuneration & Diversity Study
Opening for participation on September 2nd 2026, PIR International’s 2027 EU/UK Biotech & Life Sciences Board Remuneration & Diversity Study will provide a comprehensive, data-driven view of board remuneration, composition and diversity across the European and UK life sciences sector.
Designed as an independent, anonymised and confidential study, it will bring together insights from board leaders across the biotech and life sciences ecosystem, providing executives, investors and board members with meaningful benchmarks and perspectives to support effective board governance, remuneration decisions and board composition.
The 2027 study builds on the success of PIR International’s 2025 Board Remuneration & Diversity Study, enabling us to track how board practices, remuneration and diversity are evolving across the sector.
Who can participate?
We welcome participation from individuals serving on the Boards of European and UK biotech and life sciences companies, including those who are based in the US or elsewhere internationally:
- Chairs
- Independent Non-Executive Directors
- Executive Board Directors
- Board Advisors
Why participate?
All participants will receive access to the final, in-depth report, which is anticipated for release in January 2027. The report will provide valuable benchmarking and insight into emerging trends in board remuneration, composition and diversity, helping participants understand how their own experience compares with the wider market and informing board-level decision-making within their organisations.
Register now to receive your participation link directly to your inbox when the study opens on September 2nd 2026.
